| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/14/2010 | WO2009126655A3 Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator |
| 01/14/2010 | WO2009125999A3 Human host cell for producing recombinant proteins with high quality and quantity |
| 01/14/2010 | WO2009117098A3 Methods for stem cell production and therapy |
| 01/14/2010 | WO2009105759A9 Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof |
| 01/14/2010 | WO2009099552A3 Cell culture article and screening |
| 01/14/2010 | WO2006014505A9 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/14/2010 | WO2005097421A9 Methods for identifying risk of osteoarthritis and treatments thereof |
| 01/14/2010 | WO2003064603A9 Nucleic acid molecule encoding iwu-1 |
| 01/14/2010 | US20100011468 Fungus resistant plants and their uses |
| 01/14/2010 | US20100011467 Method for increasing resistance to pathogens in transgenic plants |
| 01/14/2010 | US20100011465 Protein Kinase Stress-Related Polypeptides and Methods of Use in Plants |
| 01/14/2010 | US20100011462 Flavin monooxygenases and transcription factors involved in glucosinolate biosynthesis |
| 01/14/2010 | US20100011461 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use |
| 01/14/2010 | US20100011460 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 01/14/2010 | US20100011459 Hybrid corn plant and seed ppvo1864 |
| 01/14/2010 | US20100011456 Nucleic Acids and Proteins and Methods for Making and Using Them |
| 01/14/2010 | US20100011455 Stem cell gene targeting |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010201 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/14/2010 | US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 01/14/2010 | US20100010196 Compositions and methods for non-targeted activation of endogenous genes |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100010099 Medium and device for proliferation of stem cells and treatment of cancer-related stem cell with resveratrol |
| 01/14/2010 | US20100010073 Microrna (mirna) for the diagnosis and treatment of heart diseases |
| 01/14/2010 | US20100010068 Liver-directed gene therapy |
| 01/14/2010 | US20100009963 Kinase antagonists |
| 01/14/2010 | US20100009913 Uses for Yerba Santa |
| 01/14/2010 | US20100009857 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/14/2010 | US20100009463 Reagents for the detection of protein phosphorylation in signaling pathways |
| 01/14/2010 | US20100009449 Preparation of Vaccine Master Cell Lines Using Recombinant Plant Suspension Cultures |
| 01/14/2010 | US20100009448 Biodegradable and bioabsorbable biomaterials and keratin fibrous articles for medical applications |
| 01/14/2010 | US20100009447 Vgamma9Vdelta2 T cell proliferation agent, method for producing activated Vgamma9Vdelta2 T cells, and uses thereof |
| 01/14/2010 | US20100009445 Rare earth nanoparticles |
| 01/14/2010 | US20100009444 System and method for controlling g-protein coupled receptor pathways |
| 01/14/2010 | US20100009443 Laboratory Apparatus for a Controlled Environment |
| 01/14/2010 | US20100009442 Stem Cell Culture Medium and Method |
| 01/14/2010 | US20100009440 Spore-like cells and uses thereof |
| 01/14/2010 | US20100009439 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS |
| 01/14/2010 | US20100009437 Isolated proteins MAGE-4 and MAGE-41 |
| 01/14/2010 | US20100009423 B. braunii, race b gene for a triterpene methyltransferase enzyme and uses thereof |
| 01/14/2010 | US20100009414 Polysaccharide transferase |
| 01/14/2010 | US20100009413 Nucleic acid molecules encoding alternansucrase |
| 01/14/2010 | US20100009410 Methods and Constructs for Expressing Polypeptide Multimers in Eukaryotic Cells Using Alternative Splicing |
| 01/14/2010 | US20100009406 Gene sequence coding formyl peptide receptor binding protein; diagnosing cancer, wound bone healing, obesity, acute heart failure, hypotension, hypertension, urinary retention, osteoporosis, restenosis, atherosclerosis, thrombosis, cardiovascular, autoimmune and nervous system disorders |
| 01/14/2010 | US20100009399 Novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells |
| 01/14/2010 | US20100009396 Method for measuring the concentration of activated factor vii (fviia) in a sample |
| 01/14/2010 | US20100009390 Mutant antibodies with high affinity for egfr |
| 01/14/2010 | US20100009384 Acyltransferase -1 (ACTR-1); for identifying modulators or are useful themselves as compositions for diagnosis and treatment of disease or disorder that arise from malfunction of the regulation of triacylglycerol (triglyceride) and phospholipid biosynthesis e.g. atherosclerosis; cardiovascular disorders |
| 01/14/2010 | US20100008992 Treatment of disc degenerative disease and compositions for same |
| 01/14/2010 | US20100008964 Isolated stromal cells and methods of using the same |
| 01/14/2010 | US20100008947 Porcine adenovirus e1 and e4 regions |
| 01/14/2010 | US20100008944 Herpes simplex virus mutant and uses therefore |
| 01/14/2010 | US20100008937 Targeted delivery to leukocytes using non-protein carriers |
| 01/14/2010 | US20100008935 Method for identifying therapeutical targets in tumors, the use thereof and means for determining and targeting angiogenesis and hemostasis related to andenocarcinomas of the lung |
| 01/14/2010 | US20100008928 Agent for preventing/treating cancer |
| 01/14/2010 | US20100008920 Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors |
| 01/14/2010 | US20100008914 Methods and compositions for treating il-4 and il-13 related fibrosis related pathologies |
| 01/14/2010 | US20100008906 Cripto binding molecules |
| 01/14/2010 | US20100008905 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 01/14/2010 | US20100008891 Production of Pluripotent Cells Through Inhibition of Bright/Arid3a Function |
| 01/14/2010 | US20100008871 New Biochemical Route to Astaxanthin |
| 01/14/2010 | US20100008866 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 01/14/2010 | US20100008853 Anti ganglioside gd3 antibodies and uses thereof |
| 01/14/2010 | CA2730300A1 Fgf-r4 receptor-specific antagonists |
| 01/14/2010 | CA2730243A1 Surface display of whole antibodies in eukaryotes |
| 01/14/2010 | CA2730153A1 A method for the formation of megamitochondria |
| 01/14/2010 | CA2730057A1 Micropatterned co-culture systems as infectious disease analysis platforms |
| 01/14/2010 | CA2729633A1 Tumor-initiating cells and methods of use |
| 01/14/2010 | CA2729602A1 Notch1 receptor binding agents and methods of use thereof |
| 01/14/2010 | CA2729303A1 Treatment of eye diseases and excessive neovascularization using a combined therapy |
| 01/14/2010 | CA2637517A1 Cold storage of modified platelets |
| 01/13/2010 | EP2144065A1 HLA-E Binding |
| 01/13/2010 | EP2143791A1 Chicken embryonic stem cell and method for evaluation thereof |
| 01/13/2010 | EP2143787A1 A method for the formation of megamitochondria |
| 01/13/2010 | EP2143732A1 T1R1 Taste receptors and genes encoding same |
| 01/13/2010 | EP2143731A1 Compounds for immunotherapy of prostate cancer and methods for their use |
| 01/13/2010 | EP2143482A1 Composite materials comprising supported porous gels |
| 01/13/2010 | EP2143481A1 Composite materials comprising supported porous gels |
| 01/13/2010 | EP2142654A1 High efficiency electroporation buffer |
| 01/13/2010 | EP2142642A1 Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics |
| 01/13/2010 | EP2142641A2 Undifferentiated stem cell culture systems |
| 01/13/2010 | EP2142568A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 01/13/2010 | EP1730523B1 Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process of spermatozoa |
| 01/13/2010 | EP1563079B1 Method of controlling cellular processes in plants |
| 01/13/2010 | EP1556486B1 Effective and stable dna enzymes |
| 01/13/2010 | EP1537218B1 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 01/13/2010 | EP1427462B1 Method for inducing selectively suppressed immune response |
| 01/13/2010 | EP1208203B1 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds |
| 01/13/2010 | EP1117802B1 Nucleic acid molecules which code a branching enzyme from bacteria of the genus neisseria, and a method for producing alpha-1,6-branched alpha-1,4-glucans |
| 01/13/2010 | CN101627114A Lithium stimulation of cord blood stem cell proliferation and growth factor production |
| 01/13/2010 | CN101627112A Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells |
| 01/13/2010 | CN101626772A Mesenchymal stem cells and uses therefor |
| 01/13/2010 | CN101624578A Cell culture medium |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |
| 01/13/2010 | CN100580079C Neural progenitor cell populations |
| 01/13/2010 | CN100580076C Cultured cell sheet package |
| 01/12/2010 | US7645925 Growing a tobacco plant having cells that contain an exogenous DNA sequence that encodes quinolate phosphoribosyl transferase functional in the cells |
| 01/12/2010 | US7645737 Polypeptides or peptides with no risk for viral infection, pathogens, prions; not evoke immune response; gelatine consists of native human collagen sequences; coating on scaffolds for tissue engineering, implant, transplant materials; component of drug delivery systems for inhibition of cancer metastasis |
| 01/12/2010 | US7645732 administering antiviral agents, very low density lipoproteins (VLDL) assembly inhibitors, such as small interfering RNA or antisense oligonucleotide directed against apolipoprotein B, or microsomal triglyceride transfer protein (MTP) inhibitors, to inhibit release of HCV from an HCV-infected cells |
| 01/12/2010 | US7645721 End group activated polymers with oligonucleotide ligands |